French drugmaker Sanofi ousted CEO Paul Hudson on Thursday ​appointed Belén Garijo, the head of German drugmaker Merck KGaA, ...

Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms ...

Blueprint Medicines, a Sanofi company, today announced AYVAKIT(R) (avapritinib) data showing clinically meaningful outcomes and a w ...

Only days after the surprise ouster of Sanofi CEO Paul Hudson, the executive roster shake-ups at the French drug giant are continuing with the appointment of a new specialty care chief. | Serving on ...

Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of ...

Sanofi has backed the $75 million series B of a rhinovirus-focused biotech with a former FDA acting commissioner at the helm. | Sanofi has backed the $75 million series B of a rhinovirus-focused ...

A handful of pharmas and celebrities are joining forces with the National Bleeding Disorders Foundation (NBDF) for a ...

Sanofi and Teva had already shown in late 2024 that the anti-TL1A antibody, called duvakitug, improved outcomes in ulcerative ...

If you are wondering whether Sanofi shares offer good value today, you are not alone. This article is designed to help you make sense of the current price tag. Sanofi's share price closed at €80.88, ...

Regeneron Pharmaceuticals and Sanofi said a key European regulatory committee has recommended expanded approval of their blockbuster anti-inflammatory drug Dupixent for younger patients with the ...

By Alessandro Parodi Feb 12 (Reuters) - French drugmaker Sanofi said on Thursday it had appointed Belén Garijo as its new chief executive after deciding not to renew the mandate of current CEO Paul ...

The Texas AG has filed a lawsuit accusing Sanofi of providing kickbacks to doctors, in the form of a free network of nurses ...